6 months in - CEO Report card

So here we are 6 months in to the new CEO's tenure. I thought this might be a good time to assess what has come to pass over the last 6 months

• SP has fallen 37% from $0.16 to $0.096
• 22nd Jan - Agreement with ITROM signed for VIVAGEL - Legacy
• 29th Jan - VIRALEZE Trail failure - Legacy
• 19th Feb - FDA Appeal failure - Legacy
• 1st Mar - Booted from All Ords - Legacy
• 8th April - Medixci partnership - Potential legacy or Cheryl run partnership)
• 22nd May - Business update (Cheryl run)
• 27th May - Positive DEP Iri results (Legacy)

So to date by my reckoning, Cheryl has produced a business update and potentially brokered a partnership with Medecxi.

Personally I was hoping for more from the new CEO.

Agreed that she should be afforded a grace period to be able to come in and pick up the pieces, but the list above does not contain much of substance.......